MCK.US McKesson Corporation

Healthcare Health Care Providers & Services USA Stocks
1,103 USD
Close of Nov 15, 2026
722.11 1,122
Market cap
USD 127B
P/E
28.4x
P/B
5.04x
ROE
-
Dividend yield
0.30%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Sep 2026.

Is MCK.US undervalued?

Graham number
Price1,103
Graham value436.74
Premium152.5%

MCK.US trades 152.5% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

McKesson Corporation fundamental analysis

No fundamental analysis for McKesson Corporation yet.

McKesson Corporation stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About McKesson Corporation

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinic…

Full company profile